A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts

References

• YathamLNKennedySHParikhSVCanadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013Bipolar Disord201315114423237061
   PubMed Web of Science ®Google Scholar
• YildizAVietaELeuchtSBaldessariniRJEfficacy of antimanic treatments: meta-analysis of randomized, controlled trialsNeuropsychopharmacology201136237538920980991
   PubMed Web of Science ®Google Scholar
• BaldessariniRJTondoLDavisPPompiliMGoodwinFKHennenJDecreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic reviewBipolar Disord200685 Pt 262563917042835
   PubMed Web of Science ®Google Scholar
• CiprianiAPrettyHHawtonKGeddesJRLithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trialsAm J Psychiatry2005162101805181916199826
   PubMed Web of Science ®Google Scholar
• CiprianiAHawtonKStocktonSGeddesJRLithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysisBMC2013346f3646
   Google Scholar
• GeddesJRBurgessSHawtonKJamisonKGoodwinGMLong-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trialsAm J Psychiatry2004161221722214754766
   PubMed Web of Science ®Google Scholar
• GrofPMüller-OerlinghausenBA critical appraisal of lithium’s efficacy and effectiveness: the last 60 yearsBipolar Disord200911Suppl 2S10S19
   Web of Science ®Google Scholar
• NivoliAMColomFMurruANew treatment guidelines for acute bipolar depression: a systematic reviewJ Affect Disord20111291–3142620538341
   PubMed Web of Science ®Google Scholar
• BauerMAldaMPrillerJYoungLTInternational Group for the Study of Lithium Treated Patients (IGSLI)Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disordersPharmacopsychiatry200336Suppl 3S250S25414677087
   PubMed Web of Science ®Google Scholar
• ChiuCTWangZHunsbergerJGChuangDMTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderPharmacol Rev201365110514223300133
   PubMed Web of Science ®Google Scholar
• ErikssonPSPerfilievaEBjörk-ErikssonTNeurogenesis in the adult human hippocampusNat Med1998411131313179809557
   PubMed Web of Science ®Google Scholar
• DumanRSDepression: a case of neuronal life and death?Biol Psychiatry200456314014515271581
   PubMed Web of Science ®Google Scholar
• Machado-VieiraRManjiHKZarateCAJrThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisBipolar Disord200911Suppl 2S92S109
   PubMed Web of Science ®Google Scholar
• Machado-VieiraRSoeiro-De-SouzaMGRichardsEMTeixeiraALZarateCAJrMultiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approachWorld J Biol Psychiatry2014152849523998912
   PubMed Web of Science ®Google Scholar
• ZarateCAJrSinghJManjiHKCellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorderBiol Psychiatry200659111006102016487491
   PubMed Web of Science ®Google Scholar
• ChangKKarchemskiyABarnea-GoralyNGarrettASimeonovaDIReissAReduced amygdalar gray matter volume in familial pediatric bipolar disorderJ Am Acad Child Adolesc Psychiatry200544656557315908839
   PubMed Web of Science ®Google Scholar
• DrevetsWCPriceJLSimpsonJRSubgenual prefrontal cortex abnormalities in mood disordersNature199738666278248279126739
   PubMed Web of Science ®Google Scholar
• MooreGJBebchukJMWildsIBChenGManjiHKLithium-induced increase in human brain grey matterLancet200035692371241124211072948
   PubMed Web of Science ®Google Scholar
• SassiRBBrambillaPHatchJPReduced left anterior cingulate volumes in untreated bipolar patientsBiol Psychiatry200456746747515450781
   PubMed Web of Science ®Google Scholar
• SelvarajSArnoneDJobDGrey matter differences in bipolar disorder: a meta-analysis of voxel-based morphometry studiesBipolar Disord201214213514522420589
   PubMed Web of Science ®Google Scholar
• AngelucciFBrenèSMathéAABDNF in schizophrenia, depression and corresponding animal modelsMol Psychiatry200510434535215655562
   PubMed Web of Science ®Google Scholar
• MonkulESMalhiGSSoaresJCAnatomical MRI abnormalities in bipolar disorder: do they exist and do they progress?Aust N Z J Psychiatry200539422222615777357
   PubMed Web of Science ®Google Scholar
• BeardenCEThompsonPMDalwaniMGreater cortical gray matter density in lithium-treated patients with bipolar disorderBiol Psychiatry200762171617240360
   PubMed Web of Science ®Google Scholar
• DrevetsWCNeuroimaging and neuropathological studies of depression: implications for the cognitive emotional features of mood disordersCur Opin Neurobiol2001112240249
   PubMed Web of Science ®Google Scholar
• HajekTKopecekMHöschlCAldaMSmaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysisJ Psychiatry Neurosci201237533334322498078
   PubMed Web of Science ®Google Scholar
• HajekTCullisJNovakTHippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatmentBipolar Disord201214326127022548899
   PubMed Web of Science ®Google Scholar
• LyooIKDagerSRKimJELithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging studyNeuropsychopharmacology20103581743175020357761
   PubMed Web of Science ®Google Scholar
• MooreGJCorteseBMGlitzDAA longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patientsJ Clin Psychiatry200970569970519389332
   PubMed Web of Science ®Google Scholar
• YucelKMcKinnonMCTaylorVHBilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI studyPsychopharmacology (Berl)2007195335736717705060
   PubMed Web of Science ®Google Scholar
• YucelKTaylorVHMcKinnonMCBilateral hippocampal volume increase in patients with bipolar disorder and short-term lithium treatmentNeuropsychopharmacology200833236136717406649
   PubMed Web of Science ®Google Scholar
• HajekTWeinerMWNeuroprotective effects of lithium in human brain? Food for thoughtCurr Alzheimer Res Epub2016218
   Web of Science ®Google Scholar
• HajekTBauerMSimhandlCNeuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment responsePsychol Med201444350751723721695
   PubMed Web of Science ®Google Scholar
• MooreGJBebchukJMHasanatKLithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects?Biol Psychiatry20004811810913502
   PubMed Web of Science ®Google Scholar
• SilverstonePHWuRHO’DonnellTUlrichMAsgharSJHanstockCCChronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patientsInt Clin Psychopharmacol200382737912598817
   PubMed Web of Science ®Google Scholar
• HajekTBauerMPfennigALarge positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre studyJ Psychiatry Neurosci201237318519222353634
   PubMed Web of Science ®Google Scholar
• ForlenzaOVCoutinhoAMAprahamianILong-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹8F]FDG-PET studyACS Chem Neurosci20145648448924730717
   PubMed Web of Science ®Google Scholar
• CaminsAVerdaguerEJunyentFPotential mechanisms involved in the prevention of neurodegenerative diseases by lithiumCNS Neurosci Ther200915433334419889130
   PubMed Web of Science ®Google Scholar
• ChuangDMNeuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?Crit Rev Neurobiol2004161–2839015581403
   PubMedGoogle Scholar
• PlotnikovEYSilachevDNZorovaLDLithium salts – simple but magicBiochemistry (Mosc)201479874074925365484
   PubMed Web of Science ®Google Scholar
• WadaAYokooHYanagitaTKobayashiHLithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseasesJ Pharmacol Sci200599430732116340157
   PubMed Web of Science ®Google Scholar
• ForlenzaOVDe-PaulaVJDinizBSNeuroprotective effects of lithium: implications for the treatment of Alzheimer’s disease and related neurodegenerative disordersACS Chem Neurosci20145644345024766396
   PubMed Web of Science ®Google Scholar
• BeurelEMichalekSMJopeRSInnate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)Trends Immunol2010311243119836308
   PubMed Web of Science ®Google Scholar
• BosettiFRintalaJSeemannRChronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brainMol Psychiatry20027884585012232777
   PubMed Web of Science ®Google Scholar
• GoldsteinBIKempDESoczynskaJKMcIntyreRSInflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literatureJ Clin Psychiatry20097081078109019497250
   PubMed Web of Science ®Google Scholar
• NahmanSBelmakerRHAzabANEffects of lithium on lipopolysaccharide-induced inflammation in rat primary glia cellsInnate Immun201218344745821994254
   PubMed Web of Science ®Google Scholar
• RapaportMHManjiHKThe effects of lithium on ex vivo cytokine productionBiol Psychiatry200150321722411513821
   PubMed Web of Science ®Google Scholar
• Chalecka-FranaszekEChuangDMLithium activates the serine/threonine kinase Akt-1 and suppresses glutamateinduced inhibition of Akt-1 activity in neuronsProc Natl Acad Sci U S A199996158745875010411946
   PubMed Web of Science ®Google Scholar
• ChenRWChuangDMLong term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression: a prominent role in neuroprotection against excitotoxicityJ Biol Chem1999274106039604210037682
   PubMed Web of Science ®Google Scholar
• ChuangDMWangZChiuCTGSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic strokeFront Mol Neurosci201141521886605
   PubMed Web of Science ®Google Scholar
• GrimesCAJopeRSThe multifaceted roles of glycogen synthase kinase 3β in cellular signalingProg Neurobiol200165439142611527574
   PubMed Web of Science ®Google Scholar
• HashimotoRTakeiNShimazuKChristLLuBChuangDMLithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicityNeuropharmacology20024371173117912504924
   PubMed Web of Science ®Google Scholar
• HashimotoRHoughCNakazawaTYamamotoTChuangDMLithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylationJ Neurochem200280458959711841566
   PubMed Web of Science ®Google Scholar
• JopeRSLithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomesTrends Biochem Sci2003249441443
   Google Scholar
• KopniskyKLChalecka-FranaszekEGonzalez-ZuluetaMChuangDMChronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activitiesNeuroscience2003116242543512559097
   PubMed Web of Science ®Google Scholar
• ManjiHKMooreGJChenGLithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illnessJ Clin Psychiatry200061Suppl 9S82S96
   PubMed Web of Science ®Google Scholar
• PatelSYenushLRodríguezPLSerranoRBlundellTLCrystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3′-phosphoadenosine-5′-phosphate phosphatase activities: a novel target of lithium therapyJ Mol Bio2002315467768511812139
   PubMed Web of Science ®Google Scholar
• KleinPSMeltonDAA molecular mechanism for the effect of lithium on developmentProc Natl Acad Sci U S A19969316845584598710892
   PubMed Web of Science ®Google Scholar
• MendesCTMuryFBde Sá MoreiraELithium reduces Gsk3b mRNA levels: implications for Alzheimer DiseaseEur Arch Psychiatry Clin Neurosci20092591162218932008
   PubMed Web of Science ®Google Scholar
• LiangMHChuangDMRegulation and function of glycogen synthase kinase-3 isoforms in neuronal survivalJ Biol Chem200728263904391717148450
   PubMed Web of Science ®Google Scholar
• QuirozJAMachado-VieiraRZarateCAJrManjiHKNovel insights into lithium’s mechanism of action: neurotrophic and neuroprotective effectsNeuropsychobiology2010621506020453535
   PubMed Web of Science ®Google Scholar
• ChinPCMajdzadehND’MelloSRInhibition of GSK3beta is a common event in neuroprotection by different survival factorsBrain Res Mol Brain Res20051371–219320115950778
   PubMedGoogle Scholar
• JopeRSRohMSGlycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventionsCurr Drug Targets20067111421143417100582
   PubMed Web of Science ®Google Scholar
• BeaulieuJMGainetdinovRRCaronMGAkt/GSK3 signaling in the action of psychotropic drugsAnnu Rev Pharmacol Toxicol20094932734718928402
   PubMed Web of Science ®Google Scholar
• AghdamSYBargerSWGlycogen synthase kinase-3 in neurodegeneration and neuroprotection: lessons from lithiumCurr Alzheimer Res200741213117316163
   PubMed Web of Science ®Google Scholar
• CarmichaelJSugarsKLBaoYPRubinszteinDCGlycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington’s disease mutationJ Biol Chem200227737337913379812097329
   PubMed Web of Science ®Google Scholar
• DinizBSMachado-VieiraRForlenzaOVLithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disordersNeuropsychiatr Dis Treat2013949350023596350
   PubMed Web of Science ®Google Scholar
• DukaTDukaVJoyceJNSidhuAAlpha-Synuclein contributes to GSK-3beta-catalyzed tau phosphorylation in Parkinson’s disease modelsFASEB J20092392820283019369384
   PubMed Web of Science ®Google Scholar
• HooperCKillickRLovestoneSThe GSK3 hypothesis of Alzheimer’s diseaseJ Neurochem200810461433143918088381
   PubMed Web of Science ®Google Scholar
• KohSHYooARChangDIHwangSJKimSHInhibition of GSK-3 reduces infarct volume and improves neurobehavioral functionsBiochem Biophys Res Commun2008371489489918477469
   PubMed Web of Science ®Google Scholar
• LeedsPRYuFWangZA new avenue for lithium: intervention in traumatic brain injuryACS Chem Neurosci20145642243324697257
   PubMed Web of Science ®Google Scholar
• LiDWLiuZQChenWYaoMLiGRAssociation of glycogen synthase kinase-3β with Parkinson’s disease (review)Mol Med Rep2014962043205024681994
   PubMed Web of Science ®Google Scholar
• KingMKPardoMChengYDowneyKJopeRSBeurelEGlycogen synthase kinase-3 inhibitors: rescuers of cognitive impairmentsPharmacol Ther2014141111223916593
   PubMed Web of Science ®Google Scholar
• MuyllaertDKremerAJaworskiTGlycogen synthase kinase-3b, or a link between amyloid and tau pathology?Genes Brain Behav20087Suppl 1S7S66
   Google Scholar
• PhielCJWilsonCALeeVMYKleinPSGSK-3α regulates production of Alzheimer’s disease amyloid-β peptidesNature2003423693843543912761548
   PubMed Web of Science ®Google Scholar
• LovestoneSDavisDRWebsterMTLithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrationsBiol Psychiatry1999458995100310386182
   PubMed Web of Science ®Google Scholar
• NobleWPlanelEZehrCInhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivoProc Natl Acad Sci U S A2005102196990699515867159
   PubMed Web of Science ®Google Scholar
• WexlerEMGeschwindDHPalmerTDLithium regulates adult hippocampal progenitor development through canonical Wnt pathway activationMol Psychiatry200813328529217968353
   PubMed Web of Science ®Google Scholar
• BradleyCAPeineauSTaghibiglouCA pivotal role of GSK-3 in synaptic plasticityFront Mol Neurosci201251322363262
   PubMed Web of Science ®Google Scholar
• HooperCMarkevichVPlattnerFGlycogen synthase kinase-3 inhibition is integral to long-term potentiationEur J Neurosci2007251818617241269
   PubMed Web of Science ®Google Scholar
• BeaulieuJMZhangXRodriguizRMRole of GSK3 beta in behavioral abnormalities induced by serotonin deficiencyProc Natl Acad Sci U S A200810541333133818212115
   PubMed Web of Science ®Google Scholar
• Kaidanovich-BeilinOMilmanAWeizmanAPickCGEldar-FinkelmanHRapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on betacatenin in mouse hippocampusBiol Psychiatry200455878178415050857
   PubMed Web of Science ®Google Scholar
• KalinichevMDawsonLAEvidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute maniaInt J Neuropsychopharmacol20111481051106721208504
   PubMed Web of Science ®Google Scholar
• RoweMKWiestCChuangDMGSK-3 is a viable potential target for therapeutic intervention in bipolar disorderNeurosci Biobehav Rev200731692093117499358
   PubMed Web of Science ®Google Scholar
• BeaulieuJMSotnikovaTDYaoWDLithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascadeProc Natl Acad Sci U S A2004101145099510415044694
   PubMed Web of Science ®Google Scholar
• GouldTDEinatHBhatRManjiHKAR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim testInt J Neuropsychopharmacol20047438739015315719
   PubMed Web of Science ®Google Scholar
• PrickaertsJMoecharsDCrynsKTransgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and maniaJ Neurosci200626359022902916943560
   PubMed Web of Science ®Google Scholar
• Kaidanovich-BeilinOLipinaTVTakaoKAbnormalities in brain structure and behavior in GSK-3alpha mutant miceMol Brain200923519925672
   PubMed Web of Science ®Google Scholar
• GouldTDEinatHO’DonnellKCBeta-catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviorsNeuropsychopharmacology200732102173218317299510
   PubMed Web of Science ®Google Scholar
• GouldTDChenGManjiHKIn vivo evidence in the brain for lithium inhibition of glycogen synthase kinase-3Neuropsychopharmacology2004291323812942141
   PubMed Web of Science ®Google Scholar
• FukumotoTMorinobuSOkamotoYKagayaAYamawakiSChronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brainPsychopharmacology2001158110010611685390
   PubMed Web of Science ®Google Scholar
• ChenGZengWZYuanPXThe mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNSJ Neurochem19997228798829930766
   PubMed Web of Science ®Google Scholar
• HuangXWuD-YChenGManjiHChenDFSupport of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2-dependent mechanismInvest Ophthalmol Vis Sci200344134735412506095
   PubMed Web of Science ®Google Scholar
• GoodwinFKJamisonKRManic-Depressive Illness: Bipolar and Recurrent Unipolar Disorders2nd edNew YorkOxford University Press2007
   Google Scholar
• YasudaSLiangMHMarinovaZYahyaviAChuangDMThe mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neuronsMol Psychiatry2009141515917925795
   PubMed Web of Science ®Google Scholar
• Dell’OssoLDel DebbioAVeltriAAssociations between brain-derived neurotrophic factor plasma levels and severity of the illness, recurrence and symptoms in depressed patientsNeuropsychobiology201062420721220714169
   PubMed Web of Science ®Google Scholar
• Machado-VieiraRDietrichMOLekeRDecreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episodeBiol Psychiatry200761214214416893527
   PubMed Web of Science ®Google Scholar
• PiccinniAMarazzitiDCatenaMPlasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatmentsJ Affect Disord20081051–327928317553570
   PubMed Web of Science ®Google Scholar
• PiccinniAVeltriACostanzoDDecreased plasma levels of brain-derived neurotrophic factor (BDNF) during mixed episodes of bipolar disorderJ Affect Disord201517116717025305432
   PubMed Web of Science ®Google Scholar
• PostRMRole of BDNF in bipolar and unipolar disorder: clinical and theoretical implicationsJ Psychiatr Res2007411297999017239400
   PubMed Web of Science ®Google Scholar
• Dell’OssoLCarmassiCDel DebbioABrain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorderProg Neuropsychopharmacol Biol Psychiatry200933589990219409951
   PubMed Web of Science ®Google Scholar
• FernandesBSSteinerJBerkMPeripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implicationsMol Psychiatry20152091108111925266124
   PubMed Web of Science ®Google Scholar
• FreyBNAndreazzaACCereserKMEffects of mood stabilizers on hippocampus BDNF levels in an animal model of maniaLife Sci200679328128616460767
   PubMed Web of Science ®Google Scholar
• EinatHYuanPGouldTDThe role of the extracellular signal-regulated kinase signaling pathway in mood modulationJ Neurosci200323197311731612917364
   PubMed Web of Science ®Google Scholar
• JacobsenJPMørkAThe effect of escitalopram, desipramine, electro-convulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levelsBrain Res200410241–218319215451381
   PubMed Web of Science ®Google Scholar
• de SousaRTvan de BiltMTDinizBSLithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week studyNeurosci Lett20114941545621362460
   PubMed Web of Science ®Google Scholar
• SuwalskaASobieskaMRybakowskiJKSerum brain-derived neurotrophic factor in euthymic bipolar patients on prophylactic lithium therapyNeuropsychobiology201062422923420714172
   PubMed Web of Science ®Google Scholar
• AngelucciFAloeLJiménez-VasquezPMathéAALithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depressionInt J Neuropsychopharmacol20036322523112974988
   PubMed Web of Science ®Google Scholar
• FreyBNAndreazzaACRosaARLithium increases nerve growth factor levels in the rat hippocampus in an animal model of maniaBehav Pharmacol200617431131816914949
   PubMed Web of Science ®Google Scholar
• GuoSAraiKStrinsMFChuangDMLoEHLithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytesStroke200940265265518974377
   PubMed Web of Science ®Google Scholar
• HellwegRLangUENagelMBaumgartnerASubchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult ratsMol Psychiatry20027660460812140783
   PubMed Web of Science ®Google Scholar
• SilvaRMartinsLLongatto-FilhoALithium prevents stress-induced reduction of vascular endothelium growth factor levelsNeurosci Lett20074291333817980489
   PubMed Web of Science ®Google Scholar
• Warner-SchmidtJLDumanRSVEGF as a potential target for therapeutic intervention in depressionCurr Opin Pharmacol200881141918061540
   PubMed Web of Science ®Google Scholar
• JopeRSA bimodal model of the mechanism of action of lithiumMol Psychiatry199941212510089004
   PubMed Web of Science ®Google Scholar
• GouldTDChenGManjiHKMood stabilizer psychopharmacologyClin Neurosci200223–4193212
   Google Scholar
• YuanPXHuangLDJiangYMGutkindJSManjiHKChenGThe mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growthJ Biol Chem200127634316743168311418608
   PubMed Web of Science ®Google Scholar
• NonakaSHoughCJChuangDMChronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influxProc Natl Acad Sci U S A1998955264226479482940
   PubMed Web of Science ®Google Scholar
• ChuangDMPrillerJPotential use of lithium in neurodegenerative disordersBauerMGrofPMuller-OerlinghausenBLithium in Neuropsychiatry: The Comprehensive GuideAbingdon, OxonInforma UK Ltd2006381398
   Google Scholar
• ChiuCTChuangDMMolecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersPharmacol Ther2010128228130420705090
   PubMed Web of Science ®Google Scholar
• HashimotoRFujimakiKJeongMRChristLChuangDMLithium-induced inhibition of Src tyrosine kinase in rat cerebral cortical neurons: a role in neuroprotection against N-methyl-D-aspartate receptor-mediated excitotoxicityFEBS Lett20035381–314514812633868
   PubMed Web of Science ®Google Scholar
• LiuYZhangGGaoCHouXNMDA receptor activation results in tyrosine phosphorylation of NMDA receptor subunit 2A(NR2A) and interaction of Pyk2 and Src with NR2A after transient cerebral ischemia and reperfusionBrain Res20019091–2515811478920
   PubMed Web of Science ®Google Scholar
• HouXYZhangGYYanJZChenMLiuYActivation of NMDA receptors and L-type voltage-gated calcium channels mediates enhanced formation of Fyn-PSD95-NR2A complex after transient brain ischemiaBrain Res20029551–212313212419528
   PubMed Web of Science ®Google Scholar
• MaJZhangGYLithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemiaNeurosci Lett2003348318518912932824
   PubMed Web of Science ®Google Scholar
• BerridgeMJDownesCPHanleyMRNeural and developmental actions of lithium: a unifying hypothesisCell19895934114192553271
   PubMed Web of Science ®Google Scholar
• ManjiHKBersudskyYChenGBelmakerRHPotterWZModulation of protein kinase C isozymes and substrates by lithium: the role of myoinositolNeuropsychopharmacology19961543703818887991
   PubMed Web of Science ®Google Scholar
• YildizAGuleryuzSAnkerstDPOngürDRenshawPFProtein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifenArch Gen Psychiatry200865325526318316672
   PubMed Web of Science ®Google Scholar
• SarkarSFlotoRABergerZLithium induces autophagy by inhibiting inositol monophosphataseJ Cell Biol200517071101111116186256
   PubMed Web of Science ®Google Scholar
• SarkarSRubinszteinDCInositol and IP3 levels regulate autophagy: biology and therapeutic speculationsAutophagy20062213213416874097
   PubMed Web of Science ®Google Scholar
• LiQLiHRoughtonKLithium reduces apoptosis and autophagy after neonatal hypoxia-ischemiaCell Death Dis20101e5621364661
   PubMed Web of Science ®Google Scholar
• ChiuCTChuangDMNeuroprotective action of lithium in disorders of the central nervous systemZhong Nan Da Xue Xue Bao Yi Xue Ban201136646147621743136
   PubMedGoogle Scholar
• WebbJLRavikumarBAtkinsJSkepperJNRubinszteinDCAlpha-Synuclein is degraded by both autophagy and the proteasomeJ Biol Chem200327827250092501312719433
   PubMed Web of Science ®Google Scholar
• RavikumarBVacherCBergerZInhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington diseaseNat Genet200436658559515146184
   PubMed Web of Science ®Google Scholar
• RubinszteinDCGestwickiJEMurphyLOKlionskyDJPotential therapeutic applications of autophagyNat Rev Drug Discov20076430431217396135
   PubMed Web of Science ®Google Scholar
• SarkarSPerlsteinEOImarisioSSmall molecules enhance autophagy and reduce toxicity in Huntington’s disease modelsNat Chem Biol20073633133817486044
   PubMed Web of Science ®Google Scholar
• KangHJNohJSBaeYSGwagBJCalcium-dependent prevention of neuronal apoptosis by lithium ion: essential role of phosphoinositide 3-kinase and phospholipase CgammaMol Pharmacol200364222823412869627
   PubMed Web of Science ®Google Scholar
• EverallIPBellCMalloryMLithium ameliorates HIV-gp120-mediated neurotoxicityMol Cell Neurosci200221349350112498789
   PubMed Web of Science ®Google Scholar
• ShalbuyevaNBrustovetskyTBrustovetskyNLithium desensitizes brain mitochondria to calcium, antagonizes permeability transition, and diminishes cytochrome C releaseJ Biol Chem200728225180571806817485418
   PubMed Web of Science ®Google Scholar
• BachmannRFWangYYuanPCommon effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damageInt J Neuropsychopharmacol200912680582219149911
   PubMed Web of Science ®Google Scholar
• BoscheBSchäferMGrafRHärtelFVSchäferUNollTLithium prevents early cytosolic calcium increase and secondary injurious calcium overload in glycolytically inhibited endothelial cellsBiochem Biophys Res Commun2013434226827223541580
   PubMed Web of Science ®Google Scholar
• Ngok-NgamPWatcharasitPThiantanawatASatayavivadJPharmacological inhibition of GSK3 attenuates DNA damage-induced apoptosis via reduction of p53 mitochondrial translocation and Bax oligomerization in neuroblastoma SH-SY5Y cellsCell Mol Biol Lett2013181587423161404
   PubMed Web of Science ®Google Scholar
• de SousaRTZarateCAJrZanettiMVOxidative stress in early stage bipolar disorder and the association with response to lithiumJ Psychiatr Res201450364124332923
   PubMed Web of Science ®Google Scholar
• KhairovaRPawarRSalvadoreGEffects of lithium on oxidative stress parameters in healthy subjectsMol Med Rep20125368068222200861
   PubMed Web of Science ®Google Scholar
• GhasemiMDehpourARThe NMDA receptor/nitric oxide pathway: a target for the therapeutic and toxic effects of lithiumTrends Pharmacol Sci201132742043421492946
   PubMed Web of Science ®Google Scholar
• ContestabileAGrecoBGhezziDTucciVBenfenatiFGaspariniLLithium rescues synaptic plasticity and memory in Down syndrome miceJ Clin Invest2013123134836123202733
   PubMed Web of Science ®Google Scholar
• GeSYangCHHsuKSMingGLSongHA critical period for enhanced synaptic plasticity in newly generated neurons of the adult brainNeuron200754455956617521569
   PubMed Web of Science ®Google Scholar
• Schmidt-HieberCJonasPBischofbergerJEnhanced synaptic plasticity in newly generated granule cells of the adult hippocampusNature2004429698818418715107864
   PubMed Web of Science ®Google Scholar
• MongiatLAEspósitoMSLombardiGSchinderAFReliable activation of immature neurons in the adult hippocampusPLoS One200944e532019399173
   PubMed Web of Science ®Google Scholar
• Marín-BurginAMongiatLAPardiMBSchinderAFUnique processing during a period of high excitation/inhibition balance in adult-born neuronsScience201233560731238124222282476
   PubMed Web of Science ®Google Scholar
• CrewsLAdameAPatrickCIncreased BMP6 levels in the brains of Alzheimer’s disease patients and APP transgenic mice are accompanied by impaired neurogenesisJ Neurosci20103037122521226220844121
   PubMed Web of Science ®Google Scholar
• GarzaJCGuoMZhangWLuXYLeptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3β/β-catenin signalingMol Psychiatry201217879080822182938
   PubMed Web of Science ®Google Scholar
• SnyderJSSoumierABrewerMPickelJCameronHAAdult hippocampal neurogenesis buffers stress responses and depressive behaviourNature2011476736145846121814201
   PubMed Web of Science ®Google Scholar
• MaoYGeXFrankCLDisrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signalingCell200913661017103119303846
   PubMed Web of Science ®Google Scholar
• CorasRSiebzehnrublFAPauliELow proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humansBrain2010133113359337220719879
   PubMed Web of Science ®Google Scholar
• BianchiPCianiEContestabileAGuidiSBartesaghiRLithium restores neurogenesis in the subventricular zone of the Ts65Dn mouse, a model for Down syndromeBrain Pathol201020110611819298631
   PubMed Web of Science ®Google Scholar
• ChenGRajkowskaGDuFSeraji-BozorgzadNManjiHKEnhancement of hippocampal neurogenesis by lithiumJ Neurochem20007541729173410987856
   PubMed Web of Science ®Google Scholar
• HashimotoRSenatorovVKanaiHLeedsPChuangD-MLithium stimulates progenitor proliferation in cultured brain neuronsNeuroscience20031171556112605892
   PubMed Web of Science ®Google Scholar
• KimJSChangMYYuITLithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivoJ Neurochem200489232433615056276
   PubMed Web of Science ®Google Scholar
• LiHLiQDuXLithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cellsJ Cereb Blood Flow Metab201131102106211521587270
   PubMed Web of Science ®Google Scholar
• YanXBHouHLWuLMLiuJZhouJNLithium regulates hippocampal neurogenesis by ERK pathway and facilitates recovery of spatial learning and memory in rats after transient global cerebral ischemiaNeuropharmacology200753448749517686496
   PubMed Web of Science ®Google Scholar
• PfennigAAldaMYoungTProphylactic lithium treatment and cognitive performance in patients with a long history of bipolar illness: no simple answers in complex disease-treatment interplayInt J Bipolar Disord20142125540718
   PubMedGoogle Scholar
• WingoAPHarveyPDBaldessariniRJNeurocognitive impairment in bipolar disorder patients: functional implicationsBipolar Disord200911211312519267694
   PubMed Web of Science ®Google Scholar
• YoungAHMore good news about the magic ion: lithium may prevent dementiaBr J Psychiatry2011198533633721525515
   PubMed Web of Science ®Google Scholar
• NunesPVForlenzaOVGattazWFLithium and risk for Alzheimer’s disease in elderly patients with bipolar disorderBr J Psychiatry200719035936017401045
   PubMed Web of Science ®Google Scholar
• KessingLVSondergardLFormanJLAndersenPKLithium treatment and risk of dementiaArch Gen Psychiatry200865111331133518981345
   PubMed Web of Science ®Google Scholar
• KessingLVFormanJLAndersenPKDoes lithium protect against dementia?Bipolar Disord2010121879420148870
   PubMed Web of Science ®Google Scholar
• MacdonaldABriggsKPoppeMHigginsAVelayudhanLLovestoneSA feasibility and tolerability study of lithium in Alzheimer’s diseaseInt J Geriatr Psychiatry200823770471118181229
   PubMed Web of Science ®Google Scholar
• HampelHEwersMBürgerKLithium trial in Alzheimer’s disease: a randomized, single-blind, placebo-controlled, multicenter 10-week studyJ Clin Psychiatry200970692293119573486
   PubMed Web of Science ®Google Scholar
• LeyheTEschweilerGWStranskyEIncrease of BDNF serum concentration in lithium treated patients with early Alzheimer’s diseaseJ Alzheimers Dis200916364965619276559
   PubMed Web of Science ®Google Scholar
• ForlenzaOVDinizBSRadanovicMSantosFSTalibLLGattazWFDisease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trialBr J Psychiatry2011198535135621525519
   PubMed Web of Science ®Google Scholar
• NunesMAVielTABuckHSMicrodose lithium treatment stabilized cognitive impairment in patients with Alzheimer’s diseaseCurr Alzheimer Res201310110410722746245
   PubMed Web of Science ®Google Scholar
• MauerSVergneDGhaemiSNStandard and trace-dose lithium: a systematic review of dementia prevention and other behavioral benefitsAust N Z J Psychiatry201448980981824919696
   PubMed Web of Science ®Google Scholar
• VoTMPerryPEllerbyMBohnertKIs lithium a neuroprotective agent?Ann Clin Psychiatry2015271495425696782
   PubMed Web of Science ®Google Scholar
• De SarnoPAxtellRCRamanCRothKAAlessiDRJopeRSLithium prevents and ameliorates experimental autoimmune encephalomyelitisJ Immunol2008181133834518566399
   PubMed Web of Science ®Google Scholar
• WataseKGatchelJRSunYLithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse modelPLoS Med200745e18217535104
   PubMed Web of Science ®Google Scholar
• ForlenzaOVAprahamianIde PaulaVJHajekTLithium, a therapy for AD: current evidence from clinical trials of neurodegenerative disordersCurr Alzheimer Res Epub2016218
   Web of Science ®Google Scholar
• KingTDBijurGNJopeRSCaspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithiumBrain Res2001919110611411689167
   PubMed Web of Science ®Google Scholar
• ArrafZAmitTYoudimMBFarahRLithium and oxidative stress lessons from the MPTP model of Parkinson’s diseaseNeurosci Lett20125161576122480690
   PubMed Web of Science ®Google Scholar
• KimYHRaneALussierSAndersenJKLithium protects against oxidative stress-mediated cell death in α-synuclein-overexpressing in vitro and in vivo models of Parkinson’s diseaseJ Neurosci Res201189101666167521710541
   PubMed Web of Science ®Google Scholar
• YoudimMBArrafZPrevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and BaxNeuropharmacology20044681130114015111020
   PubMed Web of Science ®Google Scholar
• ChenGBowerKAMaCFangSThieleCJLuoJGlycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal deathFASEB J200418101162116415132987
   PubMed Web of Science ®Google Scholar
• YongYDingHFanZLuoJKeZJLithium fails to protect dopaminergic neurons in the 6-OHDA model of Parkinson’s diseaseNeurochem Res201136336737421203835
   PubMed Web of Science ®Google Scholar
• ScheuingLChiuCTLiaoHMLinaresGRChuangDMPreclinical and clinical investigations of mood stabilizers for Huntington’s disease: what have we learned?Int J Biol Sci20141091024103825285035
   PubMed Web of Science ®Google Scholar
• WeiHQinZHSenatorovVVLithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington’s diseaseNeuroscience2001106360361211591460
   PubMed Web of Science ®Google Scholar
• SenatorovVVRenMKanaiHWeiHChuangDMShort-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington’s diseaseMol Psychiatry20049437138514702090
   PubMed Web of Science ®Google Scholar
• DanivasVMoilyNSThimmaiahROff label use of lithium in the treatment of Huntington’s disease: a case seriesIndian J Psychiatry2013551818323439971
   PubMed Web of Science ®Google Scholar
• RajaMSoletiFBentivoglioARLithium treatment in patients with Huntington disease and suicidal behaviorJ Clin Psychopharmacol201333681982124018546
   PubMed Web of Science ®Google Scholar
• FornaiFLongonePCafaroLLithium delays progression of amyotrophic lateral sclerosisProc Natl Acad Sci U S A200810562052205718250315
   PubMed Web of Science ®Google Scholar
• GillAKiddJVieiraFThompsonKPerrinSNo benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALSPLoS One200948e648919649300
   PubMed Web of Science ®Google Scholar
• PizzasegolaCCaronIDalenoCTreatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant miceAmyotroph Lateral Scler200910422122819308767
   PubMed Web of Science ®Google Scholar
• FerrucciMSpalloniABartalucciAA systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithiumNeurobiol Dis201037237038319874893
   PubMed Web of Science ®Google Scholar
• ShinJHChoSILimHRConcurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model of amyotrophic lateral sclerosisMol Pharmacol200771496597517105868
   PubMed Web of Science ®Google Scholar
• FengHLLengYMaCHZhangJRenMChuangDMCombined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse modelNeuroscience2008155356757218640245
   PubMed Web of Science ®Google Scholar
• AggarwalSPZinmanLSimpsonESafety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trialLancet Neurol20109548148820363190
   PubMed Web of Science ®Google Scholar
• Al-ChalabiAShawPJYoungCAUKMND-LiCALS. Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31]BMC Neurol20111111121936930
   PubMed Web of Science ®Google Scholar
• MorrisonKEDhariwalSHornabrookRfor UKMND-LiCALS Study GroupLithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trialLancet Neurol201312433934523453347
   PubMed Web of Science ®Google Scholar
• ChiòAMoraGThe final chapter of the ALS lithium sagaLancet Neurol201312432432523453346
   PubMed Web of Science ®Google Scholar
• BagniCTassoneFNeriGHagermanRFragile X syndrome: causes, diagnosis, mechanisms, and therapeuticsJ Clin Invest2012122124314432223202739
   PubMed Web of Science ®Google Scholar
• BhakarALDolenGBearMFThe pathophysiology of fragile X (and what it teaches about synapses)Annu Rev Neurosci20123541743322483044
   PubMed Web of Science ®Google Scholar
• GattoCLBroadieKThe fragile X mental retardation protein in circadian rhythmicity and memory consolidationMol Neurobiol200939210712919214804
   PubMed Web of Science ®Google Scholar
• EadieBDCushmanJKannangaraTSFanselowMSChristieBRNMDA receptor hypofunction in the dentate gyrus and impaired context discrimination in adult Fmr1 knockout miceHippocampus201222224125421049485
   PubMed Web of Science ®Google Scholar
• NosyrevaEDHuberKMMetabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndromeJ Neurophysiol20069553291329516452252
   PubMed Web of Science ®Google Scholar
• YunSHTrommerBLFragile X mice: reduced long-term potentiation and N-methyl-D-aspartate receptor-mediated neurotransmission in dentate gyrusJ Neurosci Res201189217618221162125
   PubMed Web of Science ®Google Scholar
• BearMFHuberKMWarrenSTThe mGluR theory of fragile X mental retardationTrends Neurosci200427737037715219735
   PubMed Web of Science ®Google Scholar
• DolenGBearMFRole for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndromeJ Physiol2008586Pt 61503150818202092
   PubMed Web of Science ®Google Scholar
• MichalonASidorovMBallardTMChronic pharmacological mGlu5 inhibition corrects fragile X in adult miceNeuron2012741495622500629
   PubMed Web of Science ®Google Scholar
• MinWWYuskaitisCJYanQElevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potentialNeuropharmacology200956246347218952114
   PubMed Web of Science ®Google Scholar
• MinesMaJopeRSGlycogen synthase kinase-3: a promising therapeutic target for fragile x syndromeFront Mol Neurosci201143522053151
   PubMed Web of Science ®Google Scholar
• PeineauSTaghibiglouCBradleyCLTP inhibits LTD in the hippocampus via regulation of GSK3betaNeuron200753570371717329210
   PubMed Web of Science ®Google Scholar
• ChoiCHSchoenfeldBPBellAJPharmacological reversal of synaptic plasticity deficits in the mouse model of fragile X syndrome by group II mGluR antagonist or lithium treatmentBrain Res2011138010611921078304
   PubMed Web of Science ®Google Scholar
• FranklinAVKingMKPalomoVMartinezAMcMahonLLJopeRSGlycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X miceBiol Psychiatry201475319820624041505
   PubMed Web of Science ®Google Scholar
• KingMKJopeRSLithium treatment alleviates impaired cognition in a mouse model of fragile X syndromeGenes Brain Behav201312772373123941202
   PubMed Web of Science ®Google Scholar
• LiuZHChuangDMSmithCBLithium ameliorates phenotypic deficits in a mouse model of fragile X syndromeInt J Neuropsychopharmacol201114561863020497624
   PubMed Web of Science ®Google Scholar
• LiuZHHuangTSmithCBLithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndromeNeurobiol Dis20124531145115222227453
   PubMed Web of Science ®Google Scholar
• MinesMAYuskaitisCJKingMKBeurelEJopeRSGSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autismPLoS One201053e970620300527
   PubMed Web of Science ®Google Scholar
• YuskaitisCJMinesMAKingMKSweattJDMillerCAJopeRSLithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndromeBiochem Pharmacol201079463264619799873
   PubMed Web of Science ®Google Scholar
• Berry-KravisESumisAHerveyCOpen-label treatment trial of lithium to target the underlying defect in fragile X syndromeJ Dev Behav Pediatr200829429330218698192
   PubMed Web of Science ®Google Scholar
• WuXBaiYTanTLithium ameliorates autistic-like behaviors induced by neonatal isolation in ratsFront Behav Neurosci2014823425018711
   PubMed Web of Science ®Google Scholar
• SerretSThümmlerSDorEVesperiniSSantosAAskenazyFLithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reportsBMC Psychiatry20151510725947967
   PubMed Web of Science ®Google Scholar
• DurandCMBetancurCBoeckersTMMutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disordersNat Genet2007391252717173049
   PubMed Web of Science ®Google Scholar
• DenayerAVan EschHde RavelTNeuropsychopathology in 7 patients with the 22q13 deletion syndrome: presence of bipolar disorder and progressive loss of skillsMol Syndromol201231142022855650
   PubMedGoogle Scholar
• VerhoevenWMEggerJIWillemsenMHde LeijerGJKleefstraTPhelan-McDermid syndrome in two adult brothers: atypical bipolar disorder as its psychopathological phenotype?Neuropsychiatr Dis Treat2012817517922570549
   PubMed Web of Science ®Google Scholar
• VerhoevenWMEggerJICohen-SnuijfRKantSGde LeeuwNPhelan-McDermid syndrome: clinical report of a 70-year-old womanAm J Med Genet A2013161A115816123166010
   PubMed Web of Science ®Google Scholar
• FernandezFMorishitaWZunigaEPharmacotherapy for cognitive impairment in a mouse model of Down syndromeNat Neurosci200710441141317322876
   PubMed Web of Science ®Google Scholar
• ChakrabartiLGaldzickiZHaydarTFDefects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndromeJ Neurosci20072743114831149517959791
   PubMed Web of Science ®Google Scholar
• ChakrabartiLBestTKCramerNPOlig1 and Olig2 triplication causes developmental brain defects in Down syndromeNat Neurosci201013892793420639873
   PubMed Web of Science ®Google Scholar
• AlgattasHHuangJHTraumatic brain injury pathophysiology and treatments: early, intermediate, and late phases post-injuryInt J Mol Sci201415130934124381049
   PubMed Web of Science ®Google Scholar
• BlennowKHardyJZetterbergHThe neuropathology and neurobiology of traumatic brain injuryNeuron201276588689923217738
   PubMed Web of Science ®Google Scholar
• OlssonACsajbokLOstMMarked increase of beta-amyloid (1–42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injuryJ Neurol2004251787087615258792
   PubMed Web of Science ®Google Scholar
• SivanandamTMThakurMKTraumatic brain injury: a risk factor for Alzheimer’s diseaseNeurosci Biobehav Rev20123651376138122390915
   PubMed Web of Science ®Google Scholar
• UryuKChenXHMartinezDMultiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humansExp Neurol2007208218519217826768
   PubMed Web of Science ®Google Scholar
• ShapiraMLichtAMilmanAPickCGShohamiEEldar-FinkelmanHRole of glycogen synthase kinase-3beta in early depressive behavior induced by mild traumatic brain injuryMol Cell Neurosci200734457157717289399
   PubMed Web of Science ®Google Scholar
• ZhuZFWangQGHanBJWilliamCPNeuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in miceBrain Res Bull201083527227720638460
   PubMed Web of Science ®Google Scholar
• DashPKJohnsonDClarkJInvolvement of the glycogen synthase kinase-3 signaling pathway in TBI pathology and neurocognitive outcomePLoS One201169e2464821935433
   PubMed Web of Science ®Google Scholar
• YuFWangZTchantchouFChiuCTZhangYChuangDMLithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injuryJ Neurotrauma201229236237421895523
   PubMed Web of Science ®Google Scholar
• RohMSEomTYZmijewskaAADe SarnoPRothKAJopeRSHypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramineBiol Psychiatry200557327828615691529
   PubMed Web of Science ®Google Scholar
• BianQShiTChuangDMQianYLithium reduces ischemia-induced hippocampal CA1 damage and behavioral deficits in gerbilsBrain Res2007118427027618028886
   PubMed Web of Science ®Google Scholar
• BijurGNJopeRSOpposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3 beta in the regulation of HSF-1 activityJ Neurochem20007562401240811080191
   PubMed Web of Science ®Google Scholar
• RenMSenatorovVVChenR-WChuangD-MPost-insult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion modelProc Natl Acad Sci U S A2003100106210621512732732
   PubMed Web of Science ®Google Scholar
• XuJHCulmanJBlumeABrechtSGohlkePChronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic deathStroke20033451287129212677021
   PubMed Web of Science ®Google Scholar
• NonakaSChuangDMNeuroprotective effects of chronic lithium on focal cerebral ischemia in ratsNeuroreport199899208120849674597
   PubMed Web of Science ®Google Scholar
• ZhengZKimJYMaHLeeJEYenariMAAnti-inflammatory effects of the 70 kDa heat shock protein in experimental strokeJ Cereb Blood Flow Metab2008281536317473852
   PubMed Web of Science ®Google Scholar
• KimYRvan MeerMPTejimaEFunctional MRI of delayed chronic lithium treatment in rat focal cerebral ischemiaStroke200839243944718187690
   PubMed Web of Science ®Google Scholar
• FanYYangGYTherapeutic angiogenesis for brain ischemia: a brief reviewJ Neuroimmune Pharmacol20072328428918040863
   PubMed Web of Science ®Google Scholar
• TsaiLKLengYWangZLeedsPChuangDMThe mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanismsNeuropsychopharmacology201035112225223720613717
   PubMed Web of Science ®Google Scholar
• TsaiLKWangZMunasingheJLengYLeedsPChuangDMMesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke modelStroke201142102932293921836090
   PubMed Web of Science ®Google Scholar
• GrayJDMcEwenBSLithium’s role in neural plasticity and its implications for mood disordersActa Psychiatr Scand2013128534736123617566
   PubMed Web of Science ®Google Scholar
• BachmannRFSchloesserRJGouldTDManjiHKMood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeuticsMol Neurobiol200532217320216215281
   PubMed Web of Science ®Google Scholar
• ChuangDMManjiHKIn search of the Holy Grail for the treatment of neurodegenerative disorders: has a simple cation been overlooked?Biol Psychiatry20076214617572175
   PubMed Web of Science ®Google Scholar
• ManjiHKMooreGJChenGClinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illnessBiol Psychiatry200048874075411063971
   PubMed Web of Science ®Google Scholar
• Dell’OssoLDalle LucheRMajMAdult autism spectrum as a transnosographic dimensionCNS Spectr201621213113326349624
   PubMed Web of Science ®Google Scholar
• InselTRRethinking schizophreniaNature2010468732118719321068826
   PubMed Web of Science ®Google Scholar